+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Animal Biotechnology Market (2021-2026) by Type, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 168 Pages
  • May 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5397319
The Global Animal Biotechnology Market is estimated to be USD 25.6 Bn in 2021 and is expected to reach USD 37.96 Bn by 2026, growing at a CAGR of 8.2%.



Market Dynamics

The major factors driving the growth of the global animal biotechnology market are the increasing prevalence of animal diseases, increasing incidence of zoonotic diseases, increased pet ownership, rising demand for meat and animal-based products, and the usage of animals in agriculture etc. Further, other significant factors such as advancements in cloning and development of transgenic animals will add to the animal's ability to fight diseases, favorable government policies and supportive approval agencies, growing research and development activities, and rising demand for animals driving the growth of this market. In addition, increasing production of new vaccines such as subunit vaccines, anti-idiotype vaccines, synthetic vaccines, and recombinant vaccines, which are practical and easy to use, is an effective way to reduce disease burden in animals and plays an essential role in preventive health and disease control, is expected to open up new market opportunities for the growth of global animal biotechnology market.

However, rising research and development expenses and ethical issues associated with animal biotechnology products are restraining the market's growth.

Market Segmentation

The Global Animal Biotechnology Market is segmented further based on Type, Application, and Geography.

By Type, the market is classified as drugs, vaccinations, diagnostic tests, genetic and reproductive products, and others. Amongst all, the drugs, segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as diagnosis of animal diseases, treatment of animal diseases, preventive care of animals, development of animal pharmaceuticals, food safety, and drug development, and others. Amongst all, the diagnosis of animal diseases segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio. - 15th April 2021
2. Boehringer Ingelheim Animal Health partners with Lifebit Biotech to utilize Artificial Intelligence (AI) to detect and early report global disease outbreaks. - 9th June 2021

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, Elanco, Genus plc, Ivaoes, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Animal Biotechnology Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Animal Biotechnology Market

What is the estimated value of the Global Animal Biotechnology Market?

The Global Animal Biotechnology Market was estimated to be valued at $25600 Million in 2021.

What is the growth rate of the Global Animal Biotechnology Market?

The growth rate of the Global Animal Biotechnology Market is 8.2%, with an estimated value of $37960 Million by 2026.

What is the forecasted size of the Global Animal Biotechnology Market?

The Global Animal Biotechnology Market is estimated to be worth $37960 Million by 2026.

Who are the key companies in the Global Animal Biotechnology Market?

Key companies in the Global Animal Biotechnology Market include Abbott Laboratories, Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, Elanco, Genus plc, Ivaoes, LLC, Intervet Inc, Merck & Co., Inc and Neogen Corporation.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Consumption of Animal Meat
4.1.2 Increasing Pet Ownership
4.1.3 Increasing Focus on Cloning & Transgenic Animals
4.2 Restraints
4.2.1 High Investment Cost for Research and Development
4.3 Opportunities
4.3.1 Rising Focus Towards R&D by Key Players
4.4 Challenges
4.4.1 Negative Impacts on Animal Welfare in the Process
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Animal Biotechnology Market, By Type
6.1 Introduction
6.2 Drugs
6.3 Vaccinations
6.4 Diagnostic Tests
6.5 Genetic and Reproductive Products
6.6 Others
7 Global Animal Biotechnology Market, By Application
7.1 Introduction
7.2 Diagnosis of Animal Diseases
7.3 Treatment of Animal Diseases
7.4 Preventive Care of Animals
7.5 Development of Animal Pharmaceuticals
7.6 Food Safety and Drug Development
7.7 Others
8 Global Animal Biotechnology Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.3.3 Chile
8.3.4 Colombia
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Netherlands
8.4.7 Sweden
8.4.8 Russia
8.4.9 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Sri Lanka
8.5.9 Thailand
8.5.10 Rest of APAC
8.6 Middle-East and Africa
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Abbott Laboratories
10.2 Bayer AG
10.3 Biogenesis Bago
10.4 Boehringer Ingelheim GmbH
10.5 Elanco, Genus plc
10.6 Ivaoes, LLC
10.7 Intervet Inc
10.8 Merck & Co., Inc
10.9 Merial
10.10 Neogen Corporation
10.11 Novartis
10.12 Pfizer, Inc
10.13 Sanofi
10.14 Santa Cruz Biotechnology, Inc
10.15 SCYNEXIS, Inc
10.16 Trans Ova Genetics
10.17 VetDC, Inc
10.18 Virbac Inc
10.19 Z-Link Biotech
10.20 Zoetis Inc
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Bayer AG
  • Biogenesis Bago
  • Boehringer Ingelheim GmbH
  • Elanco, Genus plc
  • Ivaoes, LLC
  • Intervet Inc
  • Merck & Co., Inc
  • Merial
  • Neogen Corporation
  • Novartis
  • Pfizer, Inc
  • Sanofi
  • Santa Cruz Biotechnology, Inc
  • SCYNEXIS, Inc
  • Trans Ova Genetics
  • VetDC, Inc
  • Virbac Inc
  • Z-Link Biotech
  • Zoetis Inc